ORAL α-GALACTOSIDASE IN CLINICAL PRACTICE

DOI: https://doi.org/10.29296/25877305-2018-01-18
Download full text PDF
Issue: 
1
Year: 
2018

I. Khlynov, MD; M. Chikunova, Candidate of Medical Sciences, O. Khromtsova, MD Ural State Medical University, Yekaterinburg

The paper evaluates the efficacy and safety of oral α-galactosidase for flatulence and bloating.
Keywords: 
gastroenterology
flatulence
bloating
oral α-galactosidase

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Annotatsija k BAD Orliks: svidetel'stvo o gosudarstvennoj registratsii RU.77.99.88.003.E.007871.07.15 ot 20.07.2015.
  2. Ivashkin V.T., Drapkina O.M. Propedevtika vnutrennih boleznej. Gastroenterologija: ucheb. posobie / M.: GEOTAR-Media, 2012; 160 s.
  3. Accarino A., Perez F., Azpiroz F. et al. Abdominal distention results from caudo-ventral redistribution of contents // Gastroenterology. – 2009; 136: 1544–51.
  4. Azpiroz F., Malagelada J. Abdominal bloating // Gastroenterology. – 2005; 129: 1060–78.
  5. Bengtsson B., Johansson J., Hollak C. et. al. Enzyme replacement in Anderson-Fabry disease // Lancet. – 2003; 361: 269–356.
  6. Chang L., Lee O., Naliboff B. et al. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome // Am. J. Gastroenterol. – 2001; 96: 3341–7.
  7. Chumpitazi B., Shulman R. Dietary Carbohydrates and Childhood Functional Abdominal Pain // Ann. Nutr. Metab. – 2016; 68 (l): 8–17.
  8. Di Stefano M., Miceli E., Gotti S. et al. The Effect of Oral α-Galactosidase on Intestinal Gas Production and Gas Related Symptoms // Dig. Dis. Sci. – 2007; 52 (1): 78–83.
  9. Giovanni Di Nardo, Salvatore Oliva, Federica Ferrari et al. Efficacy and tolerability of alpha-galactosidase in treating gas-related symptoms in children. A randomized, double-blind, plactbo-controlled trial // BMC Gastroenterology. – 2013; 13: 142.
  10. Hernando-Harder A., Serra J., Azpiroz F. et al. Colonic responses to gas loads in subgroups of patients with abdominal bloating // Am. J. Gastroenterol. – 2010; 10: 876–82.
  11. Hillila M., Fakkila M., Sipponen T. et al. Does oral alpha-galactosidase relieve irritable bowel symptoms? // Scand. J. Gastroenterol. – 2016; 51 (1): 16–21.
  12. Houghton L., Whorwell P. Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders // Neurogastroenterol. Motil. – 2005; 17: 500–11.
  13. Lin H. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome // JAMA. – 2004; 292: 852–8.
  14. Oh J., Lee J., Park H. et al. Alpha-Galactosidase activity in human saliva // Arch. Oral Biol. – 2008; 53 (9): 842–8.
  15. Sandler R., Stewart W., Liberman J. et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact // Dig. Dis. Sci. – 2000; 45: 1166–71.
  16. Serra J., Azpiroz F., Malagelada J. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome // Gut. – 2001; 48: 14–9.
  17. Viana P., deRezende S., Falkoski D. et al. Hydrolysis of oligosaccharides in soybean products by Debaryomyces hansenii UFV1 α-galactosidases // Food Chemistry. – 2007; 103 (2): 331–7.
  18. Zar S., Benson M., Kumar D. Review article: bloating in functional bowel disorders // Aliment. Pharmacol. Ther. – 2002; 16: 1867–76